Gregory K Friedman Selected Research

Gregory K Friedman Research Topics

Disease

29	Neoplasms (Cancer) 05/2022 - 12/2007
15	Brain Neoplasms (Brain Tumor) 11/2022 - 07/2009
10	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 11/2009
9	Glioma (Gliomas) 11/2022 - 06/2012
4	Neuroblastoma 02/2022 - 12/2007
4	Medulloblastoma 12/2021 - 02/2016
3	Fever (Fevers) 01/2020 - 11/2016
3	Neutropenia 01/2020 - 11/2016
3	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 07/2009
3	Carcinogenesis 01/2018 - 04/2012
2	Hypoxia (Hypoxemia) 01/2021 - 06/2012
2	Bacteremia 01/2020 - 01/2020
2	Ischemic Stroke 04/2019 - 01/2017
2	Herpes Simplex 01/2019 - 01/2018
2	Febrile Neutropenia 07/2018 - 11/2016
1	Disease Progression 05/2022
1	Chromothripsis 12/2021
1	Cerebellar Neoplasms 10/2020
1	Pinealoma (Pineoblastoma) 01/2020
1	Thalassemia 01/2020
1	Epilepsy (Aura) 01/2020
1	Necrosis 01/2020
1	Central Nervous System Neoplasms 01/2020
1	Mucositis 01/2020
1	Learning Disabilities (Learning Disability) 01/2020
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2020
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2019
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2019
1	Hemorrhage 02/2019
1	Supratentorial Neoplasms 02/2019
1	Lymphoma (Lymphomas) 01/2019
1	Multiple Sclerosis 01/2018
1	Oligodendroglioma 12/2017
1	Brain Ischemia (Cerebral Ischemia) 01/2017
1	Atrophy 05/2015
1	Infections 01/2015
1	Astrocytoma (Pilocytic Astrocytoma) 05/2014
1	Hepatoblastoma 01/2014
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 07/2011
1	Medullary Carcinoma 12/2010

Drug/Important Bio-Agent (IBA)

5	Biological ProductsIBA 01/2021 - 12/2007
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 04/2019
2	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 07/2011
2	Oxygen (Dioxygen)IBA 04/2019 - 06/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2018 - 11/2016
2	NectinsIBA 01/2018 - 02/2016
2	Temozolomide (Temodar)FDA LinkGeneric 12/2017 - 04/2013
2	Bevacizumab (Avastin)FDA Link 05/2015 - 04/2013
1	LigandsIBA 05/2022
1	Pharmaceutical PreparationsIBA 04/2021
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 03/2021
1	OsteopontinIBA 03/2021
1	Extracellular Matrix ProteinsIBA 03/2021
1	Focal Adhesion Protein-Tyrosine KinasesIBA 03/2021
1	IntegrinsIBA 03/2021
1	VaccinesIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Meropenem (Merrem)FDA LinkGeneric 01/2020
1	Alkylating AgentsIBA 11/2019
1	RetinoidsIBA 10/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	Interleukin-12 (IL 12)IBA 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2017
1	Immune Checkpoint ProteinsIBA 01/2017
1	UbiquitinIBA 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2016
1	Antiviral Agents (Antivirals)IBA 01/2015
1	src-Family KinasesIBA 07/2014
1	Small Interfering RNA (siRNA)IBA 05/2014
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2011
1	Prednisone (Sone)FDA LinkGeneric 07/2011
1	trans-sodium crocetinate (crocetin)IBA 01/2011
1	Carboplatin (JM8)FDA LinkGeneric 12/2010
1	Gemcitabine FDA Link 12/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2010

Therapy/Procedure

23	Therapeutics 11/2022 - 07/2009
18	Drug Therapy (Chemotherapy) 11/2022 - 07/2009
10	Oncolytic Virotherapy 11/2022 - 05/2015
8	Immunotherapy 11/2022 - 01/2017
5	Radiotherapy 01/2020 - 01/2013
3	Catheters 10/2020 - 01/2017
1	Molecular Targeted Therapy 11/2022
1	Combined Modality Therapy 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Heavy Ion Radiotherapy 12/2021
1	Splenectomy 01/2020
1	Precision Medicine 01/2019
1	Traction 01/2015
1	Aftercare (After-Treatment) 07/2011